Orangeburg, NYNCT07469384Now EnrollingIRB Ready

SCHIZOPHRENIA 1 (Disorder) Clinical Trial in Orangeburg, NY

Access cutting-edge schizophrenia 1 (disorder) treatment through this clinical trial at a research site in Orangeburg. Study-provided care at no cost to qualified participants.

Sponsored by Nathan Kline Institute for Psychiatric Research

Quick Self-Assessment

See if you qualify for this Orangeburg location

Preparing your pre-screening questions…

Expert Care in Orangeburg

Access schizophrenia 1 (disorder) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related schizophrenia 1 (disorder) treatment provided free

Apply for This Orangeburg Location

Check if you qualify for this schizophrenia 1 (disorder) clinical trial in Orangeburg, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Orangeburg

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Orangeburg site if eligible
  4. 4Begin participation

About This SCHIZOPHRENIA 1 (Disorder) Study in Orangeburg

This study investigates the ability of transcranial direct current stimulation (tDCS) applied over the motion processing area of the brain (area MT) to improve face emotion recognition (FER) ability. tDCS is a type of non-invasive brain stimulation in which low level currents are applied over the scalp to influence underlying brain function. In schizophrenia, impaired ability to detect facial motion has been shown to contribute to impaired FER, which, in turn, leads to difficulties in social cognition and poor social outcome. The study will use both fMRI and EEG to measure brain function while participants view moving dot and dynamic face stimuli. Analyses will compare changes in fMRI and EEG activity in individuals receiving active vs. sham stimulation.

Sponsor: Nathan Kline Institute for Psychiatric Research

Who Can Participate

Inclusion Criteria

Male or female subject, age 18-55
Competent and willing to sign informed consent
No more than moderately ill
SCID DSM-5 diagnosis of Sz/SzAff
WAIS IQ \>70
Does not meet current criteria for DSM-5 defined substance abuse or dependence or have a history of diagnosis within past 6 months
On medication within clinically approved range
Does not meet criteria for another DSM-5 disorder other than those judged to be minor (e.g. simple phobia)

Exclusion Criteria

Significant neurological illness or history of significant head trauma
Unstable physical illness or significant auditory/visual deficits that might interfer
Contraindication to MRI (e.g. metal implants, claustrophobia, pregnancy)
Contraindications to tDCS including metal implant, pacemaker, history of seizure, traumatic brain injury or stroke
Significant risk for suicide
Has a history of an illness, disease, condition injury, or disability which, in the opinion of the principal investigator, may interfere with the completion of all study requirements per protocol, impact the quality of the data, or the validity of the study results, including unstable physical illness, significant neurological illness, significant head trauma
Moderate or greater DSM-5 current substance use disorder, defined based on the presence of 4 or more of 11 substance use criteria within the past 12 months. In addition, individuals for whom substance use leads to not being able to perform work, home or school activities

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Orangeburg?

Yes, this clinical trial (NCT07469384) has an active research site in Orangeburg, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

SCHIZOPHRENIA 1 (Disorder) Treatment Options in Orangeburg, NY

If you're searching for schizophrenia 1 (disorder) treatment options in Orangeburg, NY, this clinical trial (NCT07469384) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Orangeburg research site is actively enrolling participants for this clinical trial. You'll receive care from experienced schizophrenia 1 (disorder) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all schizophrenia 1 (disorder) clinical trials near you to find additional studies recruiting in your area.

More Schizophrenia Trials in Orangeburg, NY

See all schizophrenia clinical trials recruiting in Orangeburg — not just this study.

Browse Schizophrenia Trials in Orangeburg →

Browse More Trials by Condition

Schizophrenia TrialsPulmonary Hypertension TrialsAll Conditions →

Ready to Join in Orangeburg?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Orangeburg, NY